Online citations, reference lists, and bibliographies.
← Back to Search

Lessons From The Cancer Genome

L. Garraway, E. Lander
Published 2013 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Systematic studies of the cancer genome have exploded in recent years. These studies have revealed scores of new cancer genes, including many in processes not previously known to be causal targets in cancer. The genes affect cell signaling, chromatin, and epigenomic regulation; RNA splicing; protein homeostasis; metabolism; and lineage maturation. Still, cancer genomics is in its infancy. Much work remains to complete the mutational catalog in primary tumors and across the natural history of cancer, to connect recurrent genomic alterations to altered pathways and acquired cellular vulnerabilities, and to use this information to guide the development and application of therapies.
This paper references
10.1038/nrc3068
SWI/SNF nucleosome remodellers and cancer
Boris G. Wilson (2011)
10.1038/nature11005
Systematic identification of genomic markers of drug sensitivity in cancer cells
M. Garnett (2012)
10.1038/nature11071
Melanoma genome sequencing reveals frequent PREX2 mutations
M. Berger (2012)
10.1126/science.1133427
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Tobias Sjöblom (2006)
IDH1 and IDH2 mutations in gliomas.
F. Ducray (2009)
10.1038/nature11826
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
M. Huch (2013)
10.1038/nbt0505-535
The Human Cancer Genome Project—one more misstep in the war on cancer
George L Gabor Miklos (2005)
10.1056/NEJMoa0810069
Mutation in TET2 in myeloid cancers.
F. Delhommeau (2009)
10.1038/nature11183
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.
Ravid Straussman (2012)
10.5167/UZH-63198
Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group
K. Flaherty (2012)
10.1182/blood-2011-12-401471
Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing.
A. Dolnik (2012)
10.1016/j.cell.2012.02.025
Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor
X. Xu (2012)
10.1038/nature09730
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
L. Pasqualucci (2011)
10.1371/journal.pone.0007887
Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples
L. Macconaill (2009)
10.1038/nature07517
Accurate Whole Human Genome Sequencing using Reversible Terminator Chemistry
D. Bentley (2008)
10.1038/nature06358
Characterizing the cancer genome in lung adenocarcinoma
B. Weir (2007)
10.1038/onc.2011.590
Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness
S. Huang (2012)
10.1056/NEJMOA020461
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.
G. Demetri (2002)
10.1038/ng.2455
Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes
M. Le Gallo (2012)
10.1126/SCIENCE.959840
The clonal evolution of tumor cell populations.
P. Nowell (1976)
10.1126/science.1196333
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
S. Jones (2010)
10.1038/nature03664
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
Levi A. Garraway (2005)
10.1038/nature10860
IDH mutation impairs histone demethylation and results in a block to cell differentiation
C. Lu (2012)
10.1038/nature11213
Novel mutations target distinct subgroups of medulloblastoma
G. Robinson (2012)
10.1038/nature08911
Chromatin remodelling during development
Lena Ho (2010)
10.1126/science.1156409
Genetic Mapping in Human Disease
D. Altshuler (2008)
10.1038/ng.907
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Yaoting Gui (2011)
10.1038/nature10662
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
P. Poulikakos (2011)
10.1126/science.1208130
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky (2011)
10.1038/nature09639
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Ignacio Varela (2011)
10.1038/nature10496
Frequent pathway mutations of splicing machinery in myelodysplasia
K. Yoshida (2011)
10.1016/S0092-8674(00)81683-9
The Hallmarks of Cancer
D. Hanahan (2000)
10.1101/gad.2009411
The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region.
Eric G. Folco (2011)
10.1056/NEJMoa1008433
ARID1A mutations in endometriosis-associated ovarian carcinomas.
Kimberly C. Wiegand (2010)
10.1038/nature08822
The landscape of somatic copy-number alteration across human cancers
R. Beroukhim (2010)
10.1056/NEJM199505253322101
Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.
M. E. Taplin (1995)
10.1126/science.1227670
Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
A. Krešo (2013)
10.1016/j.otohns.2009.05.016
Nature
R. Rosenfeld (2009)
10.1126/science.1170116
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
M. Tahiliani (2009)
10.1038/nature09744
The genomic complexity of primary human prostate cancer
M. Berger (2011)
10.1038/nature09837
Initial genome sequencing and analysis of multiple myeloma
M. A. Chapman (2011)
10.1038/ng0411-289
DNMT3A mutations in acute myeloid leukemia
M. Shah (2011)
10.1038/ng.403
The 8q24 cancer risk variant rs6983267 demonstrates long-range interaction with MYC in colorectal cancer
M. Pomerantz (2009)
10.1016/j.ccr.2010.01.020
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.
Patrick S Ward (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
R D Morin (2010)
Recurringmutations found by sequencing an acutemyeloid leukemia genome
E. R. Mardis (2009)
What's going on 造血器腫瘍 A gain-of-function mutation of JAK2 in myeloproliferative disorders. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC. N Engl J Med. 2005; 352: 1779-90. PMID:15858187.--慢性骨髄増殖性疾患においてJAK2遺伝子の変異が高頻度にみられることを示した論文
松山 智洋 (2005)
10.1007/s00439-011-1030-9
Current status of genome-wide association studies in cancer
C. Chung (2011)
10.1073/pnas.0806268105
Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
T. Shibata (2008)
10.1038/nature10351
Frequent mutation of histone modifying genes in non-Hodgkin lymphoma
R. Morin (2011)
10.1038/nm.2166
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
N. Palanisamy (2010)
10.1038/ng.2391
Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma
J. Huang (2012)
10.1093/carcin/bgr056
Genetic architecture of cancer and other complex diseases: lessons learned and future directions.
L. Hindorff (2011)
DNA sequencing of a cytogenetically normal acute myeloid leukaemia
T. J. Ley (2008)
Loss-offunction mutations in Notch receptors in cutaneous and lung squamous cell carcinoma
N J Wang (2011)
10.1038/nature08629
A small-cell lung cancer genome with complex signatures of tobacco exposure
E. Pleasance (2010)
10.1056/NEJMOA040938
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
T. Lynch (2004)
10.1038/nature09671
Oncogenically active MYD88 mutations in human lymphoma
V. Ngo (2011)
10.1038/nature07423
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding (2008)
A novel tumoursuppressor function for the Notch pathway in myeloid leukaemia
A Klinakis (2011)
10.1056/NEJMoa1103283
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.
E. Papaemmanuil (2011)
10.1038/nature03001
Finishing the euchromatic sequence of the human genome
J. Bonfield (2004)
10.1016/j.cell.2012.04.024
Mutational Processes Molding the Genomes of 21 Breast Cancers
S. Nik-Zainal (2012)
10.1038/nature09793
Asymmetric Cell Divisions Promote Notch-Dependent Epidermal Differentiation
S. Williams (2011)
10.1038/nature11404
Comprehensive genomic characterization of squamous cell lung cancers
P. Hammerman (2012)
10.1038/ng.2359
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
M. Krauthammer (2012)
10.1242/jcs.025742
Concerning the Origin of Malignant Tumours by Theodor Boveri. Translated and annotated by Henry Harris
T. Boveri (2008)
10.1200/JCO.2009.27.4944
Clinical implications of the cancer genome.
L. Macconaill (2010)
10.1073/pnas.1114669108
Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma
N. J. Wang (2011)
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin
A. Fujimoto (2012)
10.1056/NEJMoa1103782
Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
P. Chapman (2011)
10.1146/annurev-pathol-011811-132436
Molecular pathophysiology of myelodysplastic syndromes.
R. Lindsley (2013)
10.1038/ng.903
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
M. Li (2011)
10.1016/J.CCR.2006.10.009
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.
K. Chin (2006)
10.1038/nature11143
Whole Genome Analysis Informs Breast Cancer Response to Aromatase Inhibition
M. Ellis (2012)
10.1158/2159-8290.CD-11-0184
High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.
N. Wagle (2012)
10.1038/nature09807
Tumour evolution inferred by single-cell sequencing
N. Navin (2011)
10.1016/j.ccr.2010.03.017
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.
H. Noushmehr (2010)
10.1002/pros.22486
8q24 risk alleles in West African and Caribbean men
A. Murphy (2012)
10.1016/j.cell.2012.06.024
A Landscape of Driver Mutations in Melanoma
Eran Hodis (2012)
10.1016/J.YNEU.2012.05.008
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
J. Uhm (2012)
10.1056/NEJMoa1113966
PTEN mutations as a cause of constitutive insulin sensitivity and obesity.
A. Pal (2012)
10.1056/NEJMoa1109016
SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.
L. Wang (2011)
10.1002/emmm.201000070
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
D. Dias-Santagata (2010)
10.1038/nbt.1523
Solution Hybrid Selection with Ultra-long Oligonucleotides for Massively Parallel Targeted Sequencing
A. Gnirke (2009)
10.1158/2159-8290.CD-12-0012
Circumventing cancer drug resistance in the era of personalized medicine.
L. Garraway (2012)
10.1016/j.cell.2011.12.013
Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
T. Rausch (2012)
10.1073/PNAS.96.15.8681
CpG island methylator phenotype in colorectal cancer.
M. Toyota (1999)
A novel gene
R J Jaju (2001)
10.1056/NEJMoa1113205
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
M. Gerlinger (2012)
10.1038/NATURE03001
Finishing the euchromatic sequence of the human genome
D. Bensasson (2004)
10.1038/nm.2988
Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements
A. Holland (2012)
10.1038/nrg2841
Advances in understanding cancer genomes through second-generation sequencing
M. Meyerson (2010)
10.1038/ng.406
The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling
S. Tuupanen (2009)
10.1038/nature00766
Mutations of the BRAF gene in human cancer
Helen Davies (2002)
10.1016/j.leukres.2012.05.012
Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation.
H. Hájková (2012)
10.1016/j.ccr.2010.12.014
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.
W. Xu (2011)
10.1073/pnas.0910668107
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC
Nasim Ahmadiyeh (2010)
10.1186/gb-2010-11-s1-p37
Diverse somatic mutation patterns and pathway alterations in human cancers
Z. Kan (2010)
Acti - vating mutations of NOTCH 1 in human T cell acute lymphoblastic leukemia
A. P. Weng (2004)
10.1038/nrg2382
Leader of the pack: gene mapping in dogs and other model organisms
E. Karlsson (2008)
Recurringmutations found by sequencing an acutemyeloid leukemia
E. R. Mardis (2009)
10.1101/gr.134635.111
MuSiC: identifying mutational significance in cancer genomes.
N. Dees (2012)
10.1073/pnas.1121343109
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
Jens G. Lohr (2012)
10.1200/JCO.2010.33.2312
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.
N. Wagle (2011)
10.1016/S1359-6349(08)71197-2
Patterns of somatic mutation in human cancer genomes
M. Stratton (2008)
10.1016/j.ccr.2011.06.010
MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L.
K. Bernt (2011)
10.1126/scitranslmed.3001451
Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
J. Weiss (2010)
10.1007/s15015-013-0268-6
International Cancer Genome Consortium
Doris Berger (2013)
10.1038/nature11125
The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer
C. Grasso (2012)
Nat. Biotechnol
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
Punctuated evolution of prostate cancer
S. C. Baca (2013)
10.1038/nature11017
The landscape of cancer genes and mutational processes in breast cancer
P. Stephens (2012)
10.1038/nature10738
Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing
Li Ding (2012)
10.1038/ng.2246
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes
Zhi Jiang Zang (2012)
10.1126/science.1206923
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
N. Agrawal (2011)
10.1126/science.1164382
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
D. Parsons (2008)
10.1038/ng1834
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
D. Weisenberger (2006)
10.1016/j.ccr.2010.11.015
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.
M. Figueroa (2010)
10.1038/ng.2396
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
M. Peifer (2012)
10.1038/nature10910
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
J. Molenaar (2012)
10.1038/nature03669
Dynamics of chronic myeloid leukaemia
F. Michor (2005)
10.1126/SCIENCE.1099314
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
J. Paez (2004)
10.1073/pnas.1206004109
CDX2 is an amplified lineage-survival oncogene in colorectal cancer
Keyan Salari (2012)
J. Med
10.1002/path.2650
General lessons from large‐scale studies to identify human cancer predisposition genes
Jean-Baptiste Cazier (2010)
10.1200/JCO.2006.10.2731
Acute myeloid leukemia and myelodysplastic syndromes in older patients.
E. Estey (2007)
10.1073/pnas.0803379105
Drug-sensitive FGFR2 mutations in endometrial carcinoma
A. Dutt (2008)
10.1038/leu.2010.167
Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies
H. Makishima (2010)
10.1038/nature11282
Recurrent R-spondin fusions in colon cancer
S. Seshagiri (2012)
10.1038/nm.2673
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
D. Lipson (2012)
10.1056/NEJMoa1203421
Improved survival with MEK inhibition in BRAF-mutated melanoma.
K. Flaherty (2012)
10.1038/nature09999
A novel tumor suppressor function for the Notch pathway in myeloid leukemia
A. Klinakis (2011)
10.1002/PATH.2693
General lessons from large‐scale studies to identify human cancer predisposition genes. J Pathol 2010; 220: 255–262
J. Cazier (2010)
10.1038/464678a
Point: Hypotheses first
R. Weinberg (2010)
10.1016/j.cell.2012.06.013
Cancer Epigenetics: From Mechanism to Therapy
M. Dawson (2012)
10.1016/j.cell.2012.02.028
Single-Cell Exome Sequencing and Monoclonal Evolution of a JAK2-Negative Myeloproliferative Neoplasm
Yong Hou (2012)
10.1056/NEJMoa1112302
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.
J. Sosman (2012)
10.1038/ng.1032
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
V. Quesada (2012)
10.1038/ng.2291
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators
A. Fujimoto (2012)
10.1073/pnas.0710052104
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
R. Beroukhim (2007)
10.1038/nature05610
Patterns of somatic mutation in human cancer genomes
Christopher Greenman (2007)
10.1136/gut.2005.082933
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies
S. Ogino (2006)
10.1038/260170A0
DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA
D. Stéhelin (1976)
10.1038/nature10898
Transformation by the R Enantiomer of 2-Hydroxyglutarate Linked to EglN Activation
P. Koivunen (2012)
10.1158/2159-8290.CD-12-0470
A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition.
S. Whittaker (2013)
10.1182/BLOOD.V99.10.3857
NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15).
R. Rosati (2002)
10.1056/NEJMoa0903840
Recurring mutations found by sequencing an acute myeloid leukemia genome.
E. Mardis (2009)
10.1016/j.cell.2011.07.042
Chromosome Catastrophes Involve Replication Mechanisms Generating Complex Genomic Rearrangements
P. Liu (2011)
10.1126/science.1228606
Mice Lacking a Myc Enhancer That Includes Human SNP rs6983267 Are Resistant to Intestinal Tumors
Inderpreet Sur (2012)
NIH Intramural Sequencing Center (NISC) Comparative Sequencing Program
M. Le Gallo (2012)
N. Engl. J. Med
Highly Recurrent TERT Promoter Mutations in Human Melanoma
S. Horn
10.1038/ng.391
Acquired mutations in TET2 are common in myelodysplastic syndromes
S. Langemeijer (2009)
10.1126/science.1229164
Genome-Wide Detection of Single-Nucleotide and Copy-Number Variations of a Single Human Cell
Chenghang Zong (2012)
10.1126/SCIENCE.1102160
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
A. Weng (2004)
10.1200/JCO.2011.39.2092
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.
G. Marcucci (2012)
10.1038/nbt.1868
PathSeq: software to identify or discover microbes by deep sequencing of human tissue
Aleksandar D. Kostic (2011)
10.1126/SCIENCE.3945817
A turning point in cancer research: sequencing the human genome.
R. Dulbecco (1986)
10.1038/nature11412
Comprehensive molecular portraits of human breast tumors
D. Koboldt (2012)
10.1038/nature11154
Sequence analysis of mutations and translocations across breast cancer subtypes
S. Banerji (2012)
10.1038/ng.2279
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
C. Barbieri (2012)
10.1038/nature09626
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
R. Nazarian (2010)
10.1038/nature10113
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
X. S. Puente (2011)
10.1038/ng.2007.42
Genome-wide in situ exon capture for selective resequencing
E. Hodges (2007)
10.1016/j.eururo.2012.08.053
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
H. Beltran (2013)
10.1093/bioinformatics/btp120
TopHat: discovering splice junctions with RNA-Seq
C. Trapnell (2009)
10.1056/NEJM200104053441401
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
B. Druker (2001)
10.1038/nature07485
DNA sequencing of a cytogenetically normal acute myeloid leukemia genome
T. Ley (2008)
10.1038/nature08617
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
L. Dang (2009)
10.1158/2159-8274.CD-10-0022
Characterization of KRAS rearrangements in metastatic prostate cancer.
Xiaosong Wang (2011)
Wholegenome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
X S Puente (2011)
10.1073/PNAS.0405220101
EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.
W. Pao (2004)
10.1016/J.YPAT.2012.10.013
Comprehensive molecular portraits of human breast tumours
A. McCullough (2013)
10.1038/nature11547
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
A. Biankin (2012)
10.1126/SCIENCE.1096502
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Y. Samuels (2004)
J.M., and Cell
P M Pollock (1935)
10.1016/j.cell.2013.03.021
Punctuated Evolution of Prostate Cancer Genomes
Sylvan C. Baca (2013)
10.1038/nature08658
A comprehensive catalogue of somatic mutations from a human cancer genome
E. Pleasance (2010)
Chronic Myeloid Disorders
E. Papaemmanuil (2011)
10.1038/nature10833
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
J. Schwartzentruber (2012)
10.1038/ng.465
SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas
A. Bass (2009)
10.1038/nmeth.1363
BreakDancer: An algorithm for high resolution mapping of genomic structural variation
Ken Chen (2009)
10.1038/nature11003
The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity
J. Barretina (2012)
10.1016/j.cell.2010.11.055
Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
P. Stephens (2011)
10.1038/300143A0
Mechanism of activation of a human oncogene
C. Tabin (1982)
10.1038/sj.onc.1210529
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes
P. Pollock (2007)
10.1097/PPO.0b013e31823e5387
The genetics of cancer risk.
M. Pomerantz (2011)
10.1016/j.ajpath.2011.10.036
ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells.
Xuefeng Liu (2012)
10.1038/leu.2011.44
Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes
M. Walter (2011)
10.1186/gb-2011-12-8-r72
TopHat-Fusion: an algorithm for discovery of novel fusion transcripts
Daehwan Kim (2011)
10.1016/j.cell.2013.01.019
Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
D. Landau (2013)
10.1038/ng.892
Analysis of the Coding Genome of Diffuse Large B-Cell Lymphoma
L. Pasqualucci (2011)
10.1038/35057062
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium (2001)
10.1038/nbt.2514
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
K. Cibulskis (2013)
10.3410/f.6899956.7634054
Faculty Opinions recommendation of COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
J. Chernoff (2011)
10.1038/nature07385
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
R. McLendon (2008)
10.1016/0092-8674(93)90586-F
Cell
AC Tose (1993)
10.1056/NEJMoa1210093
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.
K. Flaherty (2012)
10.1016/J.CCR.2005.03.023
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
R. Levine (2005)
10.1038/nature08987
International network of cancer genome projects
T. Hudson (2010)
10.1056/NEJMOA051113
A gain-of-function mutation of JAK2 in myeloproliferative disorders.
R. Kralovics (2005)
10.1126/science.1226344
Genome Sequencing Identifies a Basis for Everolimus Sensitivity
G. Iyer (2012)
10.1038/ng1975
High-throughput oncogene mutation profiling in human cancer
R. Thomas (2007)
10.1038/nchembio.2007.18
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA
D. Kaida (2007)
10.1073/pnas.0905833106
MEK1 mutations confer resistance to MEK and B-RAF inhibition
C. Emery (2009)
10.1182/blood-2010-10-311019
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.
Anna M. Jankowska (2011)
10.1038/nature10802
DNA breaks and chromosome pulverization from errors in mitosis
Karen Crasta (2012)
10.1016/j.cell.2012.08.029
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
M. Imielinski (2012)
10.1038/nature03959
Genome sequencing in microfabricated high-density picolitre reactors
M. Margulies (2005)
10.1038/nbt.1883
Full-length transcriptome assembly from RNA-Seq data without a reference genome.
M. Grabherr (2011)
Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K
I. Luquet (2008)
10.1038/nature07943
The cancer genome
M. Stratton (2009)
10.1182/BLOOD.V98.4.1264
A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia.
R. Jaju (2001)
10.1038/onc.2009.437
Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer
Y. H. Kim (2010)
10.1038/nm.2580
Functionally Recurrent Rearrangements of the MAST Kinase and Notch Gene Families in Breast Cancer
Dan R. Robinson (2011)
10.1126/science.1145720
The Genomic Landscapes of Human Breast and Colorectal Cancers
L. Wood (2007)
10.1038/ng.520
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
J. Dupuis (2010)
10.1038/nbt.2203
Absolute quantification of somatic DNA alterations in human cancer
S. Carter (2012)
10.1038/nrclinonc.2011.165
Adaptive clinical trials in oncology
D. Berry (2012)
10.1126/science.1169786
The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain
Skirmantas Kriaucionis (2009)
10.1158/2159-8274.CD-10-0010
The BATTLE trial: personalizing therapy for lung cancer.
E. Kim (2011)
10.1016/j.cell.2012.04.023
The Life History of 21 Breast Cancers
S. Nik-Zainal (2012)
Breast Cancer Working Group of the International Cancer Genome Consortium
S Nik-Zainal
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease
H. Beltran (2012)
10.1038/NBT1186-925
Sequence the Human Genome
D. Mccormick (1986)
10.1371/journal.pgen.1001387
Characterizing Genetic Risk at Known Prostate Cancer Susceptibility Loci in African Americans
C. Haiman (2011)
10.1016/j.cell.2011.02.013
Hallmarks of Cancer: The Next Generation
D. Hanahan (2011)



This paper is referenced by
10.1007/978-3-030-45257-5_25
A Guided Network Propagation Approach to Identify Disease Genes that Combines Prior and New Information
B. Hristov (2020)
10.1158/2159-8290.CD-13-0239
Exploiting the head and neck cancer oncogenome: widespread PI3K-mTOR pathway alterations and novel molecular targets.
R. Iglesias-Bartolome (2013)
10.1016/j.cell.2015.02.038
Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis
Sidi Chen (2015)
10.1016/j.cell.2016.12.025
Insertions and Deletions Target Lineage-Defining Genes in Human Cancers
M. Imielinski (2017)
10.1038/ng.3744
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice
R. Mathur (2017)
10.1016/j.molonc.2014.03.021
Standardized decision support in next generation sequencing reports of somatic cancer variants
R. Dienstmann (2014)
10.4172/2476-2024.1000108
Fusion Genes and their Detection through Next Generation Sequencing in Malignant Hematological Disease and Solid Tumors
J. Liu (2016)
10.1101/gad.232710.113
Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.
J. Shi (2013)
10.1038/ng.2762
Emerging landscape of oncogenic signatures across human cancers
Giovanni Ciriello (2013)
10.1186/1755-8794-7-S1-S1
Concordance of deregulated mechanisms unveiled in underpowered experiments: PTBP1 knockdown case study
Vincent Gardeux (2014)
10.3978/j.issn.2304-3865.2014.05.12
The changing world of drug development.
Christian Dittrich (2014)
10.31274/ETD-180810-4245
Topics in cancer genomics
Sachet A. Shukla (2014)
Anticancer Drug Development, Challenge from Historic Perspective
Da-yong Lu (2018)
Organ size increases with obesity and correlates with cancer risk
Haley Grant Yifan Zhang (2020)
10.1103/PHYSREVE.98.032401
Model for breast cancer diversity and spatial heterogeneity
José Roberto Romero-Arias (2018)
10.1007/978-981-10-8417-1_1
Omics: A Holistic Approach in Cancer Treatment
Madhumati Bora (2018)
10.1117/12.2546320
Fluorescent imaging technologies for in situ measurement of drug target engagement and cell signaling pathways
Nathan P McMahon (2020)
10.1158/0008-5472.CAN-18-3845
Clonal Mutations Activate the NF-κB Pathway to Promote Recurrence of Nasopharyngeal Carcinoma.
R. You (2019)
10.1101/456723
PRODIGY: personalized prioritization of driver genes
Gal Dinstag (2018)
10.1007/978-3-030-32857-3_8
Precision Oncology vs Phenotypic Approaches in the Management of Cancer: A Case for the Postmitotic State
A. Aranda-Anzaldo (2020)
10.3390/genes9080402
Speciation Theory of Carcinogenesis Explains Karyotypic Individuality and Long Latencies of Cancers
Ankit Hirpara (2018)
10.1146/ANNUREV-CANCERBIO-042616-072231
Aneuploidy in Cancer: Seq-ing Answers to Old Questions
Kristin A Knouse (2017)
10.1002/prca.201300039
Molecular interaction networks in the analyses of sequence variation and proteomics data
U. Stelzl (2013)
10.1007/S40495-020-00238-1
Targeting Epigenetic Aberrations in Esophageal Squamous Cell Carcinoma
Feng Li (2020)
10.1101/525600
Cellular transformation by combined lineage conversion and oncogene expression
B. Sahu (2020)
10.1002/cac2.12091
Nasopharyngeal carcinoma joins the single‐cell party
M. Mints (2020)
10.1016/j.cels.2017.09.003
Network-Based Coverage of Mutational Profiles Reveals Cancer Genes
B. Hristov (2017)
10.2220/biomedres.37.359
Optimizing an ion semiconductor sequencing data analysis method to identify somatic mutations in the genomes of cancer cells in clinical tissue samples.
T. Nagashima (2016)
A Model of Selective Advantage for the Efficient Inference of Cancer Clonal Evolution
D. Ramazzotti (2016)
10.1016/j.sjopt.2013.06.008
Animal models in retinoblastoma research.
Rohini M. Nair (2013)
10.1016/j.cell.2013.09.011
Mapping Human Epigenomes
Chloe M. Rivera (2013)
10.1172/JCI76094
Targeting cancer with kinase inhibitors.
S. Gross (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar